Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Arch. med. res ; 29(3): 235-40, jul.-sept. 1998. tab, ilus
Article Dans Anglais | LILACS | ID: lil-232640

Résumé

Background. Genotoxicity of antibiotic has not been well evaluted, and there is not much information on the genetic risk of quinolone drugs, even though they are widely used as alternative choice drugs in urinary infections. Methods. Pipemidic acid and norfloxacin were tested for their capacity to induce point mutations using the Ames test and DNA damage on Escherichia coli PolA-/PolA+. Results. At non-toxic doses, all of the drugs studied were negative on the E. coli PolA-/PolA+ test with or without in vitro metabolic activation with induced arochlor 1254 rat liver (S9). They did not procedure frameshift mutations in TA98, or base-air substitutions in S. typhimurium hisG46 strains TA100, or UTH8414. Norfloxacin and its induced metabolites in vitro with S9 rat liver were mutagenic to hisG48 strains TA102 and TA104, both of which detect oxidative chemicals. Pipemidic acid induced mutations in S. typhimurium hisG48 strains only when they had an efficient DNA excision repair system. Conclusions. These results suggest that the risk of oxygen-free radical generation from quinolones should be considered


Sujets)
Animaux , Rats , Altération de l'ADN , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Mutation ponctuelle , Poly A , Salmonella typhimurium , Acide pipémidique/toxicité , Mutation avec décalage du cadre de lecture , Tests de mutagénicité , Norfloxacine/toxicité
SÉLECTION CITATIONS
Détails de la recherche